skip to main content
Language:

Results 1 - 10 of 157  for Great Falls College MSU

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical vein endothelial cells via blocking VEGFR signaling pathway
Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical vein endothelial cells via blocking VEGFR signaling pathway
Material Type:
Article 		Add to e-Shelf

Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical vein endothelial cells via blocking VEGFR signaling pathway

Ai, Nana ; Chong, Cheong-Meng ; Chen, Weiting ; Hu, Zhe ; Su, Huanxing ; Chen, Guokai ; Lei Wong, Queenie Wing ; Ge, Wei

Oncotarget, 2018-08-10, Vol.9 (62), p.31958-31970 [Peer Reviewed Journal]

Full text available

Citations Cited by
2
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
Material Type:
Article 		Add to e-Shelf

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation

Valentina Giudice ; Andrea Ghelli Luserna di Rorà ; Bianca Serio ; Roberto Guariglia ; Maria Benedetta Giannini ; Anna Ferrari ; Giorgia Simonetti ; Carmine Selleri ; Giovanni Martinelli

International journal of molecular sciences, 2020-12-01, Vol.21 (9724), p.9724 [Peer Reviewed Journal]

Full text available

Citations Cited by
3
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
Material Type:
Article 		Add to e-Shelf

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

Martinelli, Giovanni ; Boissel, Nicolas ; Chevallier, Patrice ; Ottmann, Oliver ; Gökbuget, Nicola ; Topp, Max S ; Fielding, Adele K ; Rambaldi, Alessandro ; Ritchie, Ellen K ; Papayannidis, Cristina ; Sterling, Lulu Ren ; Benjamin, Jonathan ; Stein, Anthony

Journal of clinical oncology, 2017-06-01, Vol.35 (16), p.1795-1802 [Peer Reviewed Journal]

Full text available

Citations Cited by
4
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
Material Type:
Article 		Add to e-Shelf

Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells

Bauer, Karin ; Berger, Daniela ; Zielinski, Christoph C ; Valent, Peter ; Grunt, Thomas W

Oncotarget, 2018-05-29, Vol.9 (41), p.26491-26506 [Peer Reviewed Journal]

Full text available

Citations Cited by
5
Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia
Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia
Material Type:
Article 		Add to e-Shelf

Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia

Marchesi, Francesco ; Salvatorelli, Emanuela ; Renzi, Daniela ; Mengarelli, Andrea ; Minotti, Giorgio ; Menna, Pierantonio

British journal of haematology, 2019-10, Vol.187 (1), p.e15-e17 [Peer Reviewed Journal]

Full text available

Citations Cited by
6
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia
Material Type:
Article 		Add to e-Shelf

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia

Musumeci, Francesca ; Greco, Chiara ; Grossi, Giancarlo ; Molinari, Alessio ; Schenone, Silvia

Cancers, 2018-11-09, Vol.10 (11), p.430 [Peer Reviewed Journal]

Full text available

Citations Cited by
7
Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention
Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention
Material Type:
Article 		Add to e-Shelf

Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention

Armenian, Saro H ; Armstrong, Gregory T ; Aune, Gregory ; Chow, Eric J ; Ehrhardt, Matthew J ; Ky, Bonnie ; Moslehi, Javid ; Mulrooney, Daniel A ; Nathan, Paul C ; Ryan, Thomas D ; van der Pal, Helena J ; van Dalen, Elvira C ; Kremer, Leontien C. M

Journal of clinical oncology, 2018, Vol.36 (21), p.2135-2144 [Peer Reviewed Journal]

Full text available

Citations Cited by
8
The ins and outs of bcr-abl inhibition
The ins and outs of bcr-abl inhibition
Material Type:
Article 		Add to e-Shelf

The ins and outs of bcr-abl inhibition

Reddy, E Premkumar ; Aggarwal, Aneel K

Genes & cancer, 2012-05, Vol.3 (5-6), p.447-454 [Peer Reviewed Journal]

Full text available

Citations Cited by
9
BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
Material Type:
Article 		Add to e-Shelf

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon

Stanchina, Michele ; McKinnell, Zoe ; Park, Jae H ; Stein, Eytan M ; Cai, Sheng F ; Taylor, Justin

Leukemia research reports, 2020, Vol.14, p.100211-100211 [Peer Reviewed Journal]

Full text available

Citations Cited by
10
Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib
Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib
Material Type:
Article 		Add to e-Shelf

Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

Englinger, Bernhard ; Laemmerer, Anna ; Moser, Patrick ; Kallus, Sebastian ; Röhrl, Clemens ; Pirker, Christine ; Baier, Dina ; Mohr, Thomas ; Niederstaetter, Laura ; Meier‐Menches, Samuel M ; Gerner, Christopher ; Gabler, Lisa ; Gojo, Johannes ; Timelthaler, Gerald ; Senkiv, Julia ; Jäger, Walter ; Kowol, Christian R ; Heffeter, Petra ; Berger, Walter

International journal of cancer, 2020-09-15, Vol.147 (6), p.1680-1693 [Peer Reviewed Journal]

Full text available

Citations Cited by

Results 1 - 10 of 157  for Great Falls College MSU

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (134)

Refine My Results

Resource Type 

  1. Articles  (151)
  2. Book Chapters  (4)
  3. Dissertations  (2)
  4. More options open sub menu

Creation Date 

From To
Refine
  1. Before 2013  (11)
  2. 2013 To 2014  (36)
  3. 2015 To 2016  (26)
  4. 2017 To 2019  (78)
  5. After 2019  (18)
  6. More options open sub menu

Language 

  1. English  (154)
  2. Russian  (1)
  3. French  (1)
  4. Japanese  (1)
  5. Korean  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait